SYRE

SPYRE THERAPEUTICS INC

SYRE·00773J202·US·Common Stock·Healthcare - Biotechnology-Activist

SYRE (SPYRE THERAPEUTICS INC) is held by 114 institutional investors as of Q1 2026. Largest holders: FMR LLC ($594.2M), BlackRock, Inc. ($278.5M), RTW INVESTMENTS, LP ($210.4M). Net institutional sentiment: Bullish.

114
Holders
(18 Elite)
$2.8B
Total Value
69% (108)
Consensus
75 buying - 33 selling
13F: Insider & Congress:
SYRESmart Money Verdict
View all
Held by 114 funds
18 elite
Who's Trading
InsiderBLBurrows Scott LSell $436KJun 25, 2026
InsiderBLBurrows Scott LSell $871KJun 25, 2026
ActivistFAFairmount Funds Management LLC9.2%Jun 23, 2026
InsiderHTHENDERSON MICHAEL THOMASSell $174KMay 8, 2026
InsiderHTHENDERSON MICHAEL THOMASSell $2.5MMay 8, 2026
InsiderHTHENDERSON MICHAEL THOMASSell $1.9MMay 8, 2026
InsiderHTHENDERSON MICHAEL THOMASSell $1.5MMay 8, 2026
InsiderTCTurtle CameronSell $369KMay 1, 2026
InsiderTCTurtle CameronSell $255KMay 1, 2026
ActivistPAPerceptive Advisors LLC5.0%Apr 22, 2026
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
11.8M(+1.2%)$594.2M0.0%+295.86%
32
Decreased
5.5M(-0.0%)$278.5M0.0%+300.12%
0
Unchanged
4.2M$210.4M2.1%+316.55%
0
New
3.1M$154.2M0.0%+143.92%
42
Decreased
2.8M(-3.2%)$140.8M1.0%+317.67%
0
Increased
2.6M(+15.2%)$131.5M0.0%+254.60%
35
Increased
1.8M(+17.8%)$92M0.0%+251.04%
35
Decreased
1.7M(-50.0%)$88.1M0.0%+337.70%
0
Increased
1.7M(+3.7%)$86.8M0.0%+252.14%
31
Decreased
1.7M(-9.4%)$83.6M0.0%+207.06%
0
Unchanged
1.6M$81.8M0.9%+206.59%
0
Decreased
1.6M(-0.2%)$80.6M0.0%+267.13%
0
Increased
1.2M(+192.6%)$61.9M0.0%+192.82%
48
Unchanged
1M$50.4M0.3%+524.71%
0
Decreased
882,833(-20.4%)$44.5M0.0%+288.10%
0
Increased
979,299(+1455.7%)$44.5M0.0%+153.23%
47
Increased
792,847(+7.1%)$40M0.1%+401.39%
37
Decreased
671,235(-1.4%)$33.9M0.0%+276.60%
0
Increased
666,564(+233.0%)$33.6M0.0%+180.82%
47
Increased
610,282(+43.4%)$30.8M0.2%+234.74%
46

Showing 1-20 of 116

1 / 6

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used